What bacteria cause high calprotectin?

Wondering what bacteria cause high calprotectin? This article explains how and why fecal calprotectin rises during gut inflammation, the types of bacteria most often linked with elevated levels, and what it can and cannot tell you about your health. You will learn how calprotectin works as an intestinal infection biomarker, which pathogenic strains are most commonly involved, and why symptoms alone rarely pinpoint the root cause. We also cover the role of gut microbiota imbalance, individual variability, and how microbiome testing can provide additional context to guide informed next steps.

Introduction

Calprotectin is a protein released by neutrophils—front-line immune cells—that becomes detectable in stool when the intestinal lining is inflamed. Clinicians use fecal calprotectin to help distinguish inflammatory conditions from functional disorders and to monitor disease activity over time. While many people ask about bacteria causing high calprotectin, the honest answer is that multiple factors can raise it, including bacterial, viral, and parasitic infections; chronic inflammatory conditions; medications; and even intense endurance exercise. Understanding when bacteria are likely involved, and which ones, can help you and your clinician decide whether further testing is needed and how to interpret results in the context of your unique microbiome.

Core Explanation of the Topic

What Is Calprotectin and Why Is It Elevated?

Calprotectin is a calcium- and zinc-binding complex (S100A8/S100A9) stored in neutrophils and monocytes. When these immune cells are recruited to the gut mucosa because of an inflammatory trigger—such as an invasive pathogen, epithelial injury, or an autoimmune process—calprotectin is released and travels into the intestinal lumen, where it can be measured in stool. Because the protein is relatively stable in feces and correlates with neutrophil activity, elevated levels serve as a practical proxy for mucosal inflammation.

Typical calprotectin elevation causes include:

• Acute infectious colitis (often bacterial, sometimes viral or parasitic)
• Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis
• Ischemic or microscopic colitis
• Medication-associated enteropathy (e.g., NSAIDs)
• Neoplasia (e.g., colorectal cancer can sometimes elevate levels)
• Recent gastrointestinal bleeding or procedures

In adults, many labs consider fecal calprotectin values under about 50 µg/g to be within reference range, 50–120 µg/g borderline, and higher levels suggestive of organic inflammation. Cutoffs vary by laboratory and clinical context. Infectious colitis and active IBD often produce substantially elevated values, though there is overlap with other conditions.

The relationship between calprotectin levels and gut health is indirect but meaningful. A normal or near-normal result makes significant mucosal inflammation less likely. An elevated result signals that something is driving neutrophil recruitment to the gut lining; identifying that “something” is the clinical challenge that follows.

Common Bacteria Linked to High Calprotectin Levels

While calprotectin is not specific to any one microorganism, certain inflammatory bacteria types are well-known to trigger robust neutrophil responses and therefore high fecal calprotectin. These include invasive enteropathogens and toxin-producing strains that damage the mucosa or disrupt epithelial integrity:

• Campylobacter jejuni/coli – A leading cause of bacterial gastroenteritis. Typically acquired from undercooked poultry or contaminated water. Often causes diarrhea (sometimes bloody), fever, and cramping, with elevated calprotectin reflecting acute colitis.
• Salmonella enterica (non-typhoidal) – Foodborne infections from eggs, poultry, or produce. The inflammatory response to invasion commonly elevates fecal calprotectin.
• Shigella spp. – Highly inflammatory and contagious; classically causes dysentery with tenesmus and blood/mucus in stool. Calprotectin can be markedly elevated due to intense neutrophilic infiltration.
• Enteroinvasive E. coli (EIEC) and Shiga-toxin producing E. coli (STEC/EHEC) – EIEC invades colonic cells similar to Shigella; STEC toxins damage the mucosa. Both can drive high calprotectin during active illness.
• Clostridioides (Clostridium) difficile – Toxin-mediated colitis associated with recent antibiotic use or healthcare settings. Calprotectin often rises substantially, tracking the inflammatory burden.
• Yersinia enterocolitica – Often from undercooked pork or contaminated food/water; can mimic appendicitis. Inflammatory changes may elevate calprotectin.
• Vibrio parahaemolyticus, Aeromonas, and Plesiomonas – Less common but recognized causes of inflammatory diarrhea, often linked to seafood or fresh water exposures.
• Enterotoxigenic Bacteroides fragilis (ETBF) – Produces a metalloprotease toxin (BFT) that can disrupt tight junctions and stimulate inflammation; associated with colitis in some settings and potentially higher calprotectin.

Beyond classic acute pathogens, certain pathobionts—resident bacteria with the potential to drive inflammation under specific conditions—are associated with chronically elevated calprotectin, especially in people with IBD or intestinal barrier dysfunction:

• Adherent-invasive Escherichia coli (AIEC) – Linked to Crohn’s disease; adheres to and invades the mucosa, triggering persistent immune activation.
• Enterobacteriaceae blooms (e.g., Klebsiella pneumoniae) – Often expand during dysbiosis, particularly with reduced microbial diversity; can correlate with inflammatory activity.
• Ruminococcus gnavus – A mucin-degrading species enriched in some IBD cohorts; associated with increased mucosal inflammation in studies.
• Enterococcus faecalis – An opportunist that can acquire virulence factors; when expanded, may contribute to inflammatory signaling.

It is important to emphasize that calprotectin is an intestinal infection biomarker in the sense that it reflects neutrophil activity often seen in infections, but elevations do not prove a bacterial cause. Viral (e.g., norovirus, rotavirus) and parasitic (e.g., Giardia, Entamoeba histolytica) infections can also elevate levels, as can noninfectious conditions. Determining whether pathogenic bacterial strains are involved usually requires stool culture, molecular pathogen panels (PCR), or other targeted diagnostics.

Why This Topic Matters for Gut Health

Identifying the driver of intestinal inflammation can change clinical decisions. For example, a bacterial cause may point toward supportive care or targeted antimicrobials, while chronic conditions like IBD typically require a different long-term strategy. Moreover, recurrent or persistent inflammation can affect nutrient absorption, barrier function, and quality of life. Misattributing symptoms to a transient “stomach bug” when the underlying issue is a smoldering microbiome imbalance—or the reverse—can delay the right investigations. Understanding where calprotectin fits and how bacteria might contribute helps set appropriate expectations for next steps, including when additional testing makes sense.

Related Symptoms, Signals, and Health Implications

High fecal calprotectin commonly accompanies symptoms of inflammatory diarrhea but the clinical picture varies. Typical features include:

• Watery or frequent stools; sometimes bloody or with mucus
• Abdominal pain or cramping, often localized in infectious colitis
• Fever, malaise, and systemic symptoms during acute infections
• Urgency and tenesmus (a sensation of incomplete evacuation)
• Unintended weight loss in more chronic or severe conditions

These symptoms overlap across bacterial, viral, and noninfectious causes. Functional disorders like IBS can present with cramping and altered bowel habits but typically have normal or only mildly elevated calprotectin. Conversely, some people with elevated calprotectin—especially athletes after intense endurance events or individuals taking certain medications—may have few gastrointestinal complaints. When symptoms persist or recur, or when calprotectin remains elevated after initial management, deeper evaluation is warranted to avoid missing hidden contributors such as microbiome dysbiosis, opportunistic pathogens, or early inflammatory disease activity.

Left unaddressed, ongoing mucosal inflammation can impact digestion and overall health by:

• Increasing intestinal permeability, which may amplify immune activation
• Altering bile acid metabolism and nutrient handling
• Reducing microbiome diversity and resilience
• Elevating the risk of complications in susceptible individuals (e.g., flares in IBD)

Individual Variability and Uncertainty

Two people can encounter the same bacterium and have very different calprotectin responses. Host genetics, prior exposures, stomach acid levels, diet, medications, and baseline microbiome composition all influence outcomes. Some individuals carry potentially pro-inflammatory strains without symptoms; others develop significant colitis from low doses of a pathogen. Even within the same condition—say, ulcerative colitis—calprotectin may track closely with symptoms in one person and less predictably in another. Day-to-day biological variability and the timing of stool collection also matter.

This variability underscores a key point: while elevated calprotectin reliably signals neutrophil-rich inflammation, it cannot specify the cause. The complexity of gut microbiota means similar symptom patterns can arise from different mechanisms—barrier disruption, toxin-mediated injury, biofilm formation, or immune dysregulation—each of which may require distinct strategies to address.

Why Symptoms Alone Do Not Reveal the Root Cause

Clinical presentation can be misleading. For example, watery diarrhea with cramps could result from viral gastroenteritis, a noninvasive bacterial toxin, an invasive bacterial colitis, or a noninfectious inflammatory flare. Without objective data, it is challenging to differentiate IBS from mild inflammatory states that wax and wane. Moreover, symptom severity does not always correlate with calprotectin magnitude; some pathogens elicit a disproportionately high neutrophil response relative to perceived discomfort, and vice versa.

Relying solely on symptoms risks both over- and under-treatment. For that reason, clinicians often use fecal calprotectin to decide whether to pursue more invasive studies (like colonoscopy) and employ targeted stool tests to clarify bacterial contributions. Objective markers reduce guesswork and help avoid unnecessary antibiotics, which can worsen microbiome imbalance when not truly needed.

The Role of the Gut Microbiome in This Context

How Microbiome Imbalances May Contribute to Elevated Calprotectin

The gut microbiome forms a dynamic ecosystem that supports barrier integrity, nutrient metabolism, and immune education. When the balance between beneficial and potentially harmful microbes shifts—often referred to as gut microbiota imbalance or dysbiosis—pro-inflammatory pathways can be amplified. Mechanisms include:

• Overgrowth of opportunists (e.g., Enterobacteriaceae) that produce endotoxins and trigger pattern-recognition receptors (like TLR4), recruiting neutrophils.
• Loss of butyrate-producing commensals (e.g., Faecalibacterium prausnitzii) that normally support mucosal energy needs and anti-inflammatory signaling.
• Mucin degradation and barrier stress by species capable of eroding the protective mucus layer, exposing the epithelium to luminal antigens.
• Biofilm formation that shields bacteria and sustains localized inflammatory niches.

In people prone to inflammatory conditions, these shifts can prime the mucosa for exaggerated immune responses to otherwise tolerable exposures, elevating calprotectin. Conversely, a resilient and diverse microbiome may buffer against large inflammatory spikes even during transient infections.

How Gut Microbiome Testing Provides Insight

Microbiome analysis uses sequencing or targeted molecular methods to characterize the composition and diversity of gut bacteria (and sometimes fungi or archaea). While it does not diagnose infections the way a clinical pathogen PCR panel does, a stool microbiome profile can highlight patterns relevant to inflammation—for example, reduced diversity, expanded pathobionts, or a low abundance of short-chain-fatty-acid producers. This context can help explain why some individuals experience recurrent calprotectin elevation or prolonged recovery after an acute infection.

When performed thoughtfully and interpreted with clinical information, stool microbiome analysis can complement standard diagnostics. It can point to imbalances that are not visible through routine stool culture and may suggest areas to discuss with a clinician, such as diet, medication effects, or further testing for specific pathogens if red flags appear.

What a Microbiome Test Can Reveal in This Context

A high-quality gut microbiome assessment may offer:

• Taxonomic composition – Which microbes are relatively abundant or depleted.
• Diversity metrics – Lower diversity often correlates with reduced ecosystem resilience.
• Signals of dysbiosis – Overrepresentation of Enterobacteriaceae or mucin-degraders that can favor neutrophil recruitment.
• Putative pathobionts – Detection of organisms associated with inflammation in research (e.g., Ruminococcus gnavus), though clinical significance requires context.
• Functional inferences – Potential capacity for short-chain fatty acid production, bile acid metabolism, or mucin degradation, depending on the platform.

Some comprehensive stool evaluations also include intestinal infection biomarkers (like calprotectin or lactoferrin) and targeted qPCR for select pathogens. However, test menus vary considerably, and not all microbiome tests measure biomarkers or detect acute infections. Always consider the scope and limitations of the chosen platform and consult a healthcare professional for interpretation.

Who Should Consider Microbiome Testing

Microbiome testing is not a substitute for medical evaluation, but it can be valuable for people who want deeper insight into patterns that may influence inflammation. It may be worth considering if you:

• Have persistent or recurrent gastrointestinal symptoms with previously elevated calprotectin
• Received inconclusive or normal results on standard diagnostics despite ongoing issues
• Suspect a hidden microbiome imbalance that might influence how your gut responds to stressors
• Want personalized context to discuss with your clinician about diet, lifestyle, or targeted next steps

If this perspective would help frame a discussion with your care team, you might consider a microbiome test as part of a broader assessment plan.

Decision-Support: When Does Testing Make Sense?

Testing strategies depend on your clinical picture, risk factors, and the trajectory of your symptoms. Situations that often warrant additional testing include:

• Chronic or recurrent digestive issues – Especially if symptoms last beyond a typical viral gastroenteritis window or keep returning.
• Elevated calprotectin that does not resolve – Persistently high or rising values after initial management may justify further work-up.
• Suspected microbiome imbalance – A history of frequent antibiotics, restricted diets, or other factors that could disrupt microbial diversity.
• Need for targeted therapy – When decisions hinge on clarifying whether inflammation is infectious, inflammatory, or dysbiosis-related.

Practical considerations:

• Timing – Collect stool for calprotectin when symptoms are representative; avoid testing immediately after colonoscopy or acute GI bleeding if possible, as results may be confounded.
• Medication review – NSAIDs can raise fecal calprotectin in some individuals; discuss with your clinician before testing.
• Follow-up – Repeat calprotectin may be used to monitor trends; a falling value often indicates inflammation is resolving.
• Test selection – Pathogen PCR panels help detect acute bacterial causes; microbiome profiling offers ecosystem context; some comprehensive stool tests combine both.

Collaboration with a healthcare professional is essential for interpretation. If you add microbiome profiling for context, make sure the results are reviewed in conjunction with clinical tests. For an example of such a tool, you can explore the InnerBuddies microbiome test, which is designed to provide educational insights into your gut ecosystem.

Mechanisms: How Bacterial Triggers Raise Calprotectin

Understanding the biology can clarify why certain pathogens are more likely to push calprotectin higher. Invasive or toxin-producing bacteria often:

• Activate pattern-recognition receptors – Lipopolysaccharide (LPS), flagellin, and other microbial-associated molecular patterns engage TLRs and NOD-like receptors, releasing chemokines (e.g., IL-8) that recruit neutrophils.
• Disrupt the epithelial barrier – Toxins and invasion compromise tight junctions and mucin layers, exposing immune cells to luminal antigens.
• Trigger oxidative bursts – Neutrophils release reactive oxygen species and antimicrobial peptides; calprotectin itself chelates zinc and manganese, limiting bacterial growth but marking inflammation.
• Perpetuate a feedback loop – Inflammatory mediators alter the local environment (pH, oxygen gradients), favoring facultative anaerobes like Enterobacteriaceae, which can further sustain inflammation.

These processes explain why infections with organisms like Shigella or toxin-positive C. difficile can produce very high fecal calprotectin and why dysbiosis can keep inflammatory pathways “primed” even after an acute event resolves.

Non-Bacterial Considerations That Mimic Bacterial Elevation

Because many people search for bacteria causing high calprotectin, it is worth highlighting conditions that can elevate levels without a bacterial culprit:

• Viral gastroenteritis – Norovirus and rotavirus can stimulate neutrophil influx and modest-to-high calprotectin.
• Parasitic infections – Giardia lamblia, Entamoeba histolytica, and others can cause inflammatory diarrhea.
• Inflammatory bowel disease – Calprotectin is widely used to monitor IBD activity; elevations may occur without a concurrent infection.
• Medication effects – NSAIDs and, less consistently, other medications can cause enteropathy and increase levels.
• Endurance exercise – Prolonged, intense efforts can transiently increase intestinal permeability and fecal calprotectin.
• Age – Infants and young children naturally have higher baseline values than adults.

These confounders underscore why careful history, review of medications, and appropriate stool testing are essential before attributing an elevation solely to bacteria.

Interpreting Calprotectin in Context

Interpreting fecal calprotectin requires a systems view. Consider:

• Magnitude and trend – Very high values are more consistent with active inflammatory or infectious colitis; stable, low-normal values argue against significant mucosal inflammation.
• Symptoms and timing – Acute onset with systemic features points toward an infection; chronic patterns suggest IBD or other noninfectious causes.
• Risk factors – Recent antibiotics, travel, food exposures, or sick contacts elevate suspicion for bacterial causes.
• Other tests – Stool culture/PCR, imaging, or endoscopy may be indicated in persistent or severe cases.
• Microbiome context – A pattern of low diversity and pathobiont expansion can help explain relapsing symptoms or slow recovery, even when acute pathogens are no longer detectable.

No single data point suffices. A combined approach minimizes assumptions and helps tailor next steps to the individual.

Practical Scenarios

Acute Bloody Diarrhea After Undercooked Poultry

A sudden illness following a high-risk meal suggests Campylobacter or Salmonella. Calprotectin may be high. A clinical pathogen panel can identify the culprit; management is usually supportive unless severe or high-risk features are present. Microbiome profiling is not needed acutely but may help later if symptoms linger.

Recurrent Cramping and Diarrhea With Fluctuating Calprotectin

When infections are ruled out and imaging is inconclusive, consider IBD, microscopic colitis, or dysbiosis contributing to episodic inflammation. A microbiome profile may reveal low diversity and pathobiont blooms that correlate with flare patterns, adding context for diet or medication discussions with a clinician.

Post-Antibiotic Diarrhea With High Calprotectin

Consider C. difficile. Prompt toxin testing or PCR is appropriate. If confirmed and treated, a follow-up calprotectin trend can help track resolution. Later, microbiome testing may illuminate lingering dysbiosis after antibiotic therapy.

Limitations and Responsible Use of Testing

Calprotectin does not identify specific bacteria. Microbiome tests do not replace clinical diagnostics for acute infections. Sequencing methods capture relative abundance rather than absolute counts and may miss low-level pathogens or transient exposures. Importantly, the presence of a microbe does not necessarily imply causation; context matters. Results are best interpreted alongside clinical evaluation, diet and medication history, and, when indicated, targeted pathogen tests.

Connecting the Dots: Your Personal Gut Microbiome

Your microbiome is as individual as your fingerprint. Two people with similar calprotectin values may have very different microbial networks, immune settings, and triggers. Moving beyond guessing means integrating symptoms, biomarkers, clinical diagnostics, and personalized ecosystem insights. For some, adding a microbiome testing snapshot provides a useful educational framework for informed conversations with healthcare professionals and more intentional lifestyle choices.

Key Takeaways

• Fecal calprotectin reflects neutrophil-driven intestinal inflammation; it is not specific to a single cause.
• Common bacterial culprits include Campylobacter, Salmonella, Shigella, EIEC/STEC, C. difficile, Yersinia, and certain pathobionts.
• Viral, parasitic, inflammatory, medication-related, and exercise-related factors can also elevate calprotectin.
• Symptoms overlap widely; objective testing reduces uncertainty and supports better decisions.
• Gut microbiota imbalance can predispose to higher or prolonged inflammation and recurrent elevations.
• Microbiome profiling offers ecosystem context but does not replace clinical pathogen testing.
• Trends over time and combined data (history, labs, imaging) improve interpretation.
• Individual variability means similar symptoms can have different root causes.
• Consider microbiome testing if you have persistent symptoms, prior elevations, or suspected dysbiosis.
• Work with a healthcare professional to interpret results and plan next steps responsibly.

Q&A

Which bacteria most commonly cause high fecal calprotectin?

Invasive and toxin-producing enteric pathogens are frequent culprits: Campylobacter, Salmonella, Shigella, enteroinvasive E. coli (EIEC), Shiga-toxin E. coli (STEC), C. difficile, and Yersinia. These organisms trigger strong neutrophil recruitment to the gut mucosa, which is reflected as elevated calprotectin.

Can a high calprotectin result prove I have a bacterial infection?

No. Calprotectin indicates inflammation but is not organism-specific. Viral and parasitic infections, inflammatory bowel disease, certain medications, and other conditions can also elevate levels. Identifying bacteria typically requires targeted stool culture or PCR panels.

How high does calprotectin get with bacterial infections?

Levels vary widely by pathogen, host response, and timing. Infectious colitis can produce high or very high results, sometimes exceeding several hundred micrograms per gram. However, there is overlap with IBD and other inflammatory states, so magnitude alone does not establish the cause.

Do probiotics lower calprotectin?

Some studies suggest certain probiotic strains can modestly influence inflammatory markers in specific contexts, but results are inconsistent and strain-dependent. Calprotectin should not be used to evaluate probiotics in isolation, and any decisions are best made with a clinician familiar with your history.

Can irritable bowel syndrome (IBS) cause high calprotectin?

IBS is generally considered a functional disorder and usually shows normal or only mildly elevated calprotectin. A persistently elevated value suggests additional evaluation for inflammatory or infectious causes rather than IBS alone.

Does Helicobacter pylori raise fecal calprotectin?

H. pylori mainly affects the stomach and is typically assessed with breath, stool antigen, or biopsy tests. Because fecal calprotectin reflects intestinal neutrophil activity, H. pylori infection is not a typical reason for high fecal calprotectin in the lower gut.

Could medications be raising my calprotectin?

Yes. Nonsteroidal anti-inflammatory drugs (NSAIDs) can cause enteropathy and increase fecal calprotectin in some people. Always review medications and supplements with your clinician when interpreting results.

Should I repeat the calprotectin test?

Repeating calprotectin can be useful for monitoring trends, especially after an acute illness or treatment. Falling values often indicate resolving inflammation. Timing and frequency should be discussed with your healthcare professional.

What is the role of microbiome testing if I have high calprotectin?

Microbiome testing can reveal patterns of dysbiosis—low diversity, pathobiont expansion, or functional imbalances—that may predispose to or perpetuate inflammation. It complements, but does not replace, clinical diagnostics for acute infections.

Can a microbiome test identify the exact pathogen causing my symptoms?

Not necessarily. Many microbiome platforms focus on community composition rather than pathogen detection. Clinical stool PCR or culture remains the standard for diagnosing specific acute bacterial infections.

Is a normal calprotectin result always reassuring?

A normal result makes significant neutrophil-rich inflammation less likely, which is reassuring in many contexts. However, no single test is perfect; persistent concerning symptoms warrant medical evaluation regardless of one normal value.

When should I consider a comprehensive stool panel?

If you have severe symptoms, blood in stool, fever, recent travel or high-risk exposures, or persistent elevation after initial management, a clinician may order targeted pathogen panels. For broader ecosystem context, a microbiome profile such as the InnerBuddies microbiome test can be added to inform discussions, but it is not a diagnostic test for acute infections.

Keywords

bacteria causing high calprotectin, gut microbiota imbalance, intestinal infection biomarkers, inflammatory bacteria types, calprotectin elevation causes, pathogenic bacterial strains, fecal calprotectin, infectious colitis, Clostridioides difficile, Campylobacter, Salmonella, Shigella, Enterobacteriaceae, dysbiosis, microbiome testing, stool biomarker, neutrophil inflammation, IBD vs IBS, stool PCR